511 related articles for article (PubMed ID: 21278141)
1. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction.
Gu J; Song ZP; Gui DM; Hu W; Chen YG; Zhang DD
Cardiovasc Toxicol; 2012 Dec; 12(4):341-9. PubMed ID: 22763982
[TBL] [Abstract][Full Text] [Related]
3. HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis.
Zhang C; Qu S; Wei X; Feng Y; Zhu H; Deng J; Wang K; Liu K; Liu M; Zhang H; Xiao X
Cell Stress Chaperones; 2016 Mar; 21(2):251-60. PubMed ID: 26515559
[TBL] [Abstract][Full Text] [Related]
4. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Attenuates Cardiomyocyte Apoptosis in Rats Induced by Coronary Microembolization Through SIRT1-Mediated Deacetylation of p53.
Mao Q; Liang X; Wu Y; Lu Y
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):551-558. PubMed ID: 31046448
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.
Kim DH; Jung YJ; Lee JE; Lee AS; Kang KP; Lee S; Park SK; Han MK; Lee SY; Ramkumar KM; Sung MJ; Kim W
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F427-35. PubMed ID: 21593185
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
9. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
10. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
Su S; Li Q; Liu Y; Xiong C; Li J; Zhang R; Niu Y; Zhao L; Wang Y; Guo H
Toxicol Lett; 2014 Jan; 224(2):257-63. PubMed ID: 24211423
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation.
Hu YX; Cui H; Fan L; Pan XJ; Wu JH; Shi SZ; Cui SY; Wei ZM; Liu L
Can J Physiol Pharmacol; 2013 Dec; 91(12):1044-54. PubMed ID: 24289075
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis.
Sin TK; Tam BT; Yung BY; Yip SP; Chan LW; Wong CS; Ying M; Rudd JA; Siu PM
J Physiol; 2015 Apr; 593(8):1887-99. PubMed ID: 25665036
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress.
Xin YF; Wan LL; Peng JL; Guo C
Food Chem Toxicol; 2011 Jan; 49(1):259-64. PubMed ID: 21056614
[TBL] [Abstract][Full Text] [Related]
14. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
Patel N; Joseph C; Corcoran GB; Ray SD
Toxicol Appl Pharmacol; 2010 Jun; 245(2):143-52. PubMed ID: 20144634
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
16. [Metallothionein inhibited DOX-induced cardiac apoptosis in mice].
Shuai Y; Guo J; Peng SQ; Zhang LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):620-3. PubMed ID: 17718425
[TBL] [Abstract][Full Text] [Related]
17. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
Tian XQ; Ni XW; Xu HL; Zheng L; ZhuGe DL; Chen B; Lu CT; Yuan JJ; Zhao YZ
Int J Nanomedicine; 2017; 12():7103-7119. PubMed ID: 29026304
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
Childs AC; Phaneuf SL; Dirks AJ; Phillips T; Leeuwenburgh C
Cancer Res; 2002 Aug; 62(16):4592-8. PubMed ID: 12183413
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway.
Liu MH; Lin XL; Guo DM; Zhang Y; Yuan C; Tan TP; Chen YD; Wu SJ; Ye ZF; He J
Mol Med Rep; 2016 Feb; 13(2):1281-6. PubMed ID: 26675978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
